ABVC BioPharma, Inc.
ABVC
$1.62
$0.085.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.81M | -3.80M | -4.42M | -7.55M | -8.80M |
| Total Depreciation and Amortization | 313.50K | 302.10K | 482.20K | 482.70K | 476.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 339.90K | 2.25M | 3.00M | 4.61M | 4.55M |
| Change in Net Operating Assets | -717.30K | -1.04M | -1.29M | -1.30M | 124.10K |
| Cash from Operations | -1.88M | -2.29M | -2.23M | -3.76M | -3.65M |
| Capital Expenditure | -- | -- | 0.00 | -21.20K | -21.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 154.20K | 101.60K | -339.00K |
| Cash from Investing | -- | -- | 154.20K | 80.40K | -360.20K |
| Total Debt Issued | 689.60K | 1.00M | 422.20K | -1.40M | -1.43M |
| Total Debt Repaid | -385.40K | -356.10K | -365.60K | -186.50K | -186.50K |
| Issuance of Common Stock | 1.39M | 978.50K | 902.20K | 1.92M | 1.05M |
| Repurchase of Common Stock | -7.30K | -7.30K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.30K | 612.10K | 726.90K | 3.16M | 3.16M |
| Cash from Financing | 1.73M | 2.23M | 1.69M | 3.49M | 2.59M |
| Foreign Exchange rate Adjustments | 243.00K | 210.10K | 37.70K | 191.80K | 284.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.60K | 147.00K | -351.10K | 500.00 | -1.13M |